JMP Securities Maintains Wix.com(WIX.US) With Buy Rating, Maintains Target Price $180
KeyBanc Initiates Wix.com(WIX.US) With Hold Rating
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20
Monday Com Price Target Announced at $250.00/Share by Baird
Monday.Com Analyst Ratings
Baird Initiates Monday.com(MNDY.US) With Hold Rating, Announces Target Price $250
Jefferies Remains a Buy on Pagaya Technologies Ltd (PGY)
Cellebrite DI's Strategic Expansion Into Federal Cybersecurity Market Prompts Buy Rating
Analysts Offer Insights on Technology Companies: Palantir Technologies (PLTR), Cellebrite DI (CLBT) and Array Technologies (ARRY)
Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)
Cellebrite DI (CLBT) Receives a Buy From Craig-Hallum
Nova Analyst Ratings
Monday.Com Analyst Ratings
Piper Sandler Maintains Overweight on Monday.Com, Maintains $270 Price Target
Piper Sandler Remains a Buy on Monday.com (MNDY)
Teva Pharmaceutical Indus Analyst Ratings
UBS Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $24
Argus Upgrades Teva to Buy, Cites Recent Drug Approvals
Wolfe Research Initiates Coverage On Monday.Com With Outperform Rating, Announces Price Target of $300
Monday.Com Analyst Ratings